OriginalSourceNew York PostUnited StatesLeanCenter-rightCredibilityPublished10:37 UTCRatings: AllSides, MBFCSourceNew York PostUnited StatesLeanCenter-rightCredibilityPublished10:37 UTCRatings: AllSides, MBFC
“Thousands of blood pressure medication bottles recalled nationwide after pills fail quality test”
Thousands of blood pressure bottles recalled after failing dissolution tests
Key points
- Macleods Pharma USA recalled specific lots of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets nationwide.
- Recall covers 3,528 30-count bottles (lot 12251163A) and 216 90-count bottles (lot 12251163B).
- Bottles expire May 31, 2027 and bear NDCs 33342-246-07 (30-count) and 33342-246-10 (90-count).
- FDA classifies the recall as Class II due to failed dissolution specifications during testing.
- Recall began Oct. 7; FDA classified it as of Oct. 26; action remains ongoing nationwide.
How it got here
New York Post publishes the article.
concise reads it.